HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum

The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C >...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2685-2691
Hauptverfasser: Fournier, Natalie, Paul, Jean-Louis, Atger, Veronique, Cogny, Anne, Soni, Theophile, de la Llera-Moya, Margarita, Rothblat, George, Moatti, Nicole
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2691
container_issue 11
container_start_page 2685
container_title Arteriosclerosis, thrombosis, and vascular biology
container_volume 17
creator Fournier, Natalie
Paul, Jean-Louis
Atger, Veronique
Cogny, Anne
Soni, Theophile
de la Llera-Moya, Margarita
Rothblat, George
Moatti, Nicole
description The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L < HDL-C < 1.50 mmol/L) and a high-HDL group (HDL-C > 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P < .0001) and positively correlated with the proportion of HDL-SM (r = .43, P < .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)
doi_str_mv 10.1161/01.atv.17.11.2685
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79487087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>25294228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhiMEKqXwAzggWQhxy-LxRxwfV2mXRVoEEoWr5U0c1otjp3ZC6ZVfjqNd9cBp5p15ZjSatyheA14BVPABw0pPv1cgslyRquZPikvghJWsotXTnGMhS14x8rx4kdIRY8wIwRfFhWRYEkYvi7_b6x36eghpPARnR9uhJvjJ-Alpv-TDGJKdbPBIJ6TRZ30MEW10O-VwbSYTB-ut_4maPG5S1sGhm7538x_U6FG3dnpAmxgGtJn5eosa41xCU0DbedAefTNxHl4Wz3rtknl1jlfF983NbbMtd18-fmrWu7LlDGRZUypaDZTWQuy55l21h9p0NesNZVIaLqAztDWEYs1EhTGFfU-ASN51PdGGXhXvT3vHGO7mfKwabGrzQdqbMCclJKsFrkUG3_4HHsMcfb5NkfzAuqaYZghOUBtDStH0aox20PFBAVaLOQqDWt_-UCCyVIs5eebNefG8H0z3OHF2I_ffnfs6tdr1UfvWpkeMAK6wgIyxE3YfXP54-uXmexPVwWg3HdRiMq0wL0FKAZBluZQk_QerU6YU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204288303</pqid></control><display><type>article</type><title>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Fournier, Natalie ; Paul, Jean-Louis ; Atger, Veronique ; Cogny, Anne ; Soni, Theophile ; de la Llera-Moya, Margarita ; Rothblat, George ; Moatti, Nicole</creator><creatorcontrib>Fournier, Natalie ; Paul, Jean-Louis ; Atger, Veronique ; Cogny, Anne ; Soni, Theophile ; de la Llera-Moya, Margarita ; Rothblat, George ; Moatti, Nicole</creatorcontrib><description>The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L &lt; HDL-C &lt; 1.50 mmol/L) and a high-HDL group (HDL-C &gt; 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P &lt; .0001) and positively correlated with the proportion of HDL-SM (r = .43, P &lt; .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)</description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/01.atv.17.11.2685</identifier><identifier>PMID: 9409243</identifier><identifier>CODEN: ATVBFA</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Animals ; Apolipoproteins - blood ; Biological and medical sciences ; Cholesterol - metabolism ; Cholesterol, HDL - analysis ; Disorders of blood lipids. Hyperlipoproteinemia ; Humans ; Hypercholesterolemia - blood ; Lipoproteins, HDL - blood ; Liver - metabolism ; Liver Neoplasms, Experimental - metabolism ; Liver Neoplasms, Experimental - pathology ; Male ; Medical sciences ; Metabolic diseases ; Phosphatidylethanolamines - blood ; Phospholipids - blood ; Rats ; Sphingomyelins - blood ; Tumor Cells, Cultured</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2685-2691</ispartof><rights>1997 American Heart Association, Inc.</rights><rights>1998 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Nov 1997</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</citedby><cites>FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2106071$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9409243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fournier, Natalie</creatorcontrib><creatorcontrib>Paul, Jean-Louis</creatorcontrib><creatorcontrib>Atger, Veronique</creatorcontrib><creatorcontrib>Cogny, Anne</creatorcontrib><creatorcontrib>Soni, Theophile</creatorcontrib><creatorcontrib>de la Llera-Moya, Margarita</creatorcontrib><creatorcontrib>Rothblat, George</creatorcontrib><creatorcontrib>Moatti, Nicole</creatorcontrib><title>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description>The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L &lt; HDL-C &lt; 1.50 mmol/L) and a high-HDL group (HDL-C &gt; 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P &lt; .0001) and positively correlated with the proportion of HDL-SM (r = .43, P &lt; .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)</description><subject>Animals</subject><subject>Apolipoproteins - blood</subject><subject>Biological and medical sciences</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol, HDL - analysis</subject><subject>Disorders of blood lipids. Hyperlipoproteinemia</subject><subject>Humans</subject><subject>Hypercholesterolemia - blood</subject><subject>Lipoproteins, HDL - blood</subject><subject>Liver - metabolism</subject><subject>Liver Neoplasms, Experimental - metabolism</subject><subject>Liver Neoplasms, Experimental - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Phosphatidylethanolamines - blood</subject><subject>Phospholipids - blood</subject><subject>Rats</subject><subject>Sphingomyelins - blood</subject><subject>Tumor Cells, Cultured</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhiMEKqXwAzggWQhxy-LxRxwfV2mXRVoEEoWr5U0c1otjp3ZC6ZVfjqNd9cBp5p15ZjSatyheA14BVPABw0pPv1cgslyRquZPikvghJWsotXTnGMhS14x8rx4kdIRY8wIwRfFhWRYEkYvi7_b6x36eghpPARnR9uhJvjJ-Alpv-TDGJKdbPBIJ6TRZ30MEW10O-VwbSYTB-ut_4maPG5S1sGhm7538x_U6FG3dnpAmxgGtJn5eosa41xCU0DbedAefTNxHl4Wz3rtknl1jlfF983NbbMtd18-fmrWu7LlDGRZUypaDZTWQuy55l21h9p0NesNZVIaLqAztDWEYs1EhTGFfU-ASN51PdGGXhXvT3vHGO7mfKwabGrzQdqbMCclJKsFrkUG3_4HHsMcfb5NkfzAuqaYZghOUBtDStH0aox20PFBAVaLOQqDWt_-UCCyVIs5eebNefG8H0z3OHF2I_ffnfs6tdr1UfvWpkeMAK6wgIyxE3YfXP54-uXmexPVwWg3HdRiMq0wL0FKAZBluZQk_QerU6YU</recordid><startdate>199711</startdate><enddate>199711</enddate><creator>Fournier, Natalie</creator><creator>Paul, Jean-Louis</creator><creator>Atger, Veronique</creator><creator>Cogny, Anne</creator><creator>Soni, Theophile</creator><creator>de la Llera-Moya, Margarita</creator><creator>Rothblat, George</creator><creator>Moatti, Nicole</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>199711</creationdate><title>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</title><author>Fournier, Natalie ; Paul, Jean-Louis ; Atger, Veronique ; Cogny, Anne ; Soni, Theophile ; de la Llera-Moya, Margarita ; Rothblat, George ; Moatti, Nicole</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5419-8337ca133877b5a5d6b18ed84fe3499e571de3ce230a4760031bf21295ddf2ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Apolipoproteins - blood</topic><topic>Biological and medical sciences</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol, HDL - analysis</topic><topic>Disorders of blood lipids. Hyperlipoproteinemia</topic><topic>Humans</topic><topic>Hypercholesterolemia - blood</topic><topic>Lipoproteins, HDL - blood</topic><topic>Liver - metabolism</topic><topic>Liver Neoplasms, Experimental - metabolism</topic><topic>Liver Neoplasms, Experimental - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Phosphatidylethanolamines - blood</topic><topic>Phospholipids - blood</topic><topic>Rats</topic><topic>Sphingomyelins - blood</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fournier, Natalie</creatorcontrib><creatorcontrib>Paul, Jean-Louis</creatorcontrib><creatorcontrib>Atger, Veronique</creatorcontrib><creatorcontrib>Cogny, Anne</creatorcontrib><creatorcontrib>Soni, Theophile</creatorcontrib><creatorcontrib>de la Llera-Moya, Margarita</creatorcontrib><creatorcontrib>Rothblat, George</creatorcontrib><creatorcontrib>Moatti, Nicole</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fournier, Natalie</au><au>Paul, Jean-Louis</au><au>Atger, Veronique</au><au>Cogny, Anne</au><au>Soni, Theophile</au><au>de la Llera-Moya, Margarita</au><au>Rothblat, George</au><au>Moatti, Nicole</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>1997-11</date><risdate>1997</risdate><volume>17</volume><issue>11</issue><spage>2685</spage><epage>2691</epage><pages>2685-2691</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><coden>ATVBFA</coden><abstract>The relationships of cell cholesterol efflux to HDL phospholipid (PL) content and composition in human serum were analyzed in two groups of subjects selected on the basis of their HDL cholesterol (HDL-C) levelsa norm-HDL group (1.10 mmol/L &lt; HDL-C &lt; 1.50 mmol/L) and a high-HDL group (HDL-C &gt; 1.75 mmol/L). In the high-HDL group, the relative fractional efflux was significantly higher than in the norm-HDL group, and in both groups, fractional efflux was correlated with a number of lipoprotein parameters, the best correlation and the only one that remained significant after multivariate analysis being with HDL phospholipid (HDL-PL). Analysis of the HDL-PL subclasses revealed that HDL in the high-HDL sera was enriched with phosphatidylethanolamine (HDL-PE) and relatively deficient in sphingomyelin (HDL-SM) compared with norm-HDL sera. Moreover, the fractional efflux values in the high-HDL group were negatively correlated with the proportion of HDL-PE (r = -.64, P &lt; .0001) and positively correlated with the proportion of HDL-SM (r = .43, P &lt; .01). Thus, this study provides evidence that HDL-PL concentration can he used to predict the capacity of serum to accept cellular cholesterol. Among the differences described between norm-HDL and high-HDL sera, the variability in PE to SM ratio might reflect changes in serum cholesterol acceptors that modulate the first step of reverse cholesterol transport. (Arterioscler Thromb Vasc Biol. 1997;17:2685-2691.)</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9409243</pmid><doi>10.1161/01.atv.17.11.2685</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1079-5642
ispartof Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.2685-2691
issn 1079-5642
1524-4636
language eng
recordid cdi_proquest_miscellaneous_79487087
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Animals
Apolipoproteins - blood
Biological and medical sciences
Cholesterol - metabolism
Cholesterol, HDL - analysis
Disorders of blood lipids. Hyperlipoproteinemia
Humans
Hypercholesterolemia - blood
Lipoproteins, HDL - blood
Liver - metabolism
Liver Neoplasms, Experimental - metabolism
Liver Neoplasms, Experimental - pathology
Male
Medical sciences
Metabolic diseases
Phosphatidylethanolamines - blood
Phospholipids - blood
Rats
Sphingomyelins - blood
Tumor Cells, Cultured
title HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A21%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HDL%20Phospholipid%20Content%20and%20Composition%20as%20a%20Major%20Factor%20Determining%20Cholesterol%20Efflux%20Capacity%20From%20Fu5AH%20Cells%20to%20Human%20Serum&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Fournier,%20Natalie&rft.date=1997-11&rft.volume=17&rft.issue=11&rft.spage=2685&rft.epage=2691&rft.pages=2685-2691&rft.issn=1079-5642&rft.eissn=1524-4636&rft.coden=ATVBFA&rft_id=info:doi/10.1161/01.atv.17.11.2685&rft_dat=%3Cproquest_cross%3E25294228%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204288303&rft_id=info:pmid/9409243&rfr_iscdi=true